![Huma Qamar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Huma Qamar
Inga fler pågående positioner
Förmögenhet: 5 456 $ per 2026-07-31
Profil
Huma Qamar formerly worked at Ocugen, Inc., as Chief Medical Officer from 2024 to 2026, Quantum BioPharma Ltd., as Head-Research & Development, and Medicus Pharma Ltd., as Chief Scientific Officer from 2023 to 2024.
Dr. Qamar received her doctorate degree from Army Medical College.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
OCUGEN INC 0 % | 2026-07-27 | 4 436 ( 0 % ) | 5 456 $ | 2026-07-31 |
Tidigare kända positioner av Huma Qamar
| Företag | Position | Slut |
|---|---|---|
| OCUGEN, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2026-05-08 |
| QUANTUM BIOPHARMA LTD. | Teknisk/Vetenskaplig/F&U Direktör | - |
Huma Qamars utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
4
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Army Medical College
 Army Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FSD Pharma, Inc.
 FSD Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurodegenerative, inflammatory and metabolic disorders | Health Technology |
Ocugen, Inc.
 Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
